Molecular Therapy — Nucleic Acids · 2019 · 32 citations · 30 references
Life SciencesCardiologyCell BiologyApoptosisGene ExpressionInnate ImmunityApoptosis ModulationApoptosis RegulationCardiovascular DiseaseCell DeathIschemic Heart DiseaseNecrosisApoptosis-regulating MicrornasMechanisms Of Cardiac InjuryMicrorna In ApoptosisMicrorna Regulation Of ApoptosisNecroptotic SignalingProgrammed Cell Death PathwaysProgrammed Cell Death RegulationProgrammed Necrosis
Recent studies have shown that several upstream signaling elements of apoptosis and necroptosis are closely associated with acute injury in the heart. In our study, we observed that miR-105 was notably dysregulated in rat hearts with myocardial infarction (MI). Thus, the purpose of this study was to test the hypothesis that miR-105 participates in the regulation of RIP3/p-MLKL- and BNIP3-dependent necroptosis/apoptosis in H9c2 cells and MI rat hearts. Our results show that the RIP3/p-MLKL necroptotic pathway and BNIP3-dependent apoptosis signaling are enhanced in H9c2 cells under hypoxic conditions, whereas, compared with these pathways in the controls, those in miR-105-treated H9c2 cells are suppressed. Mechanistically, we identified miR-105 as the miRNA directly suppressing the expression of RIP3 and BNIP3, two important mediators involved in cell necroptosis and apoptosis. Furthermore, MI rat hearts injected with miR-105 had decreased infarct sizes, indicating that miR-105 is among three miRNAs that function simultaneously to suppress necroptotic/apoptotic cell death pathways and to inhibit MI-induced cardiomyocyte cell death at multiple levels. Taken together, miR-105 may constitute a new therapeutic strategy for cardioprotection in ischemic heart disease.
30
CaMKII is a RIP3 substrate mediating ischemia- and oxidative stress–induced myocardial necroptosis
Ting Zhang, Yan Zhang, Mingyao Cui et al. · Nature Medicine · 2016 · 793 citations